ATE260895T1 - Indometacin calciumsalz pentahydrat und deren herstellung - Google Patents
Indometacin calciumsalz pentahydrat und deren herstellungInfo
- Publication number
- ATE260895T1 ATE260895T1 AT98400170T AT98400170T ATE260895T1 AT E260895 T1 ATE260895 T1 AT E260895T1 AT 98400170 T AT98400170 T AT 98400170T AT 98400170 T AT98400170 T AT 98400170T AT E260895 T1 ATE260895 T1 AT E260895T1
- Authority
- AT
- Austria
- Prior art keywords
- calcium salt
- indometacin
- production
- salt pentahydrate
- pentahydrate
- Prior art date
Links
- 229960000905 indomethacin Drugs 0.000 title abstract 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 title abstract 3
- IGBSGKOLQRKFIU-UHFFFAOYSA-N O.O.O.O.O.[Ca] Chemical compound O.O.O.O.O.[Ca] IGBSGKOLQRKFIU-UHFFFAOYSA-N 0.000 title 1
- 235000011086 calcium lactate Nutrition 0.000 title 1
- 239000001527 calcium lactate Substances 0.000 title 1
- -1 Pentahydrate indometacine calcium salt Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
- C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9700925A FR2758819B1 (fr) | 1997-01-29 | 1997-01-29 | Indometacine calcique et sa preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE260895T1 true ATE260895T1 (de) | 2004-03-15 |
Family
ID=9503072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98400170T ATE260895T1 (de) | 1997-01-29 | 1998-01-28 | Indometacin calciumsalz pentahydrat und deren herstellung |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0856511B1 (de) |
AT (1) | ATE260895T1 (de) |
DE (1) | DE69822009T2 (de) |
ES (1) | ES2217512T3 (de) |
FR (1) | FR2758819B1 (de) |
MA (1) | MA24450A1 (de) |
PT (1) | PT856511E (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2820636B1 (fr) * | 2001-02-09 | 2007-10-05 | Laprophan Laboratoires De Prod | Utilisation de l'indometacine calcique pour traiter les pathologies a mediation de la cyclo-oxygenase 2 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK244179A (da) * | 1978-06-13 | 1979-12-14 | Merck & Co Inc | Fremgangsmaade til fremstilling af krystallinsk natrium og kaliumindomethacin og trihydrater deraf |
JPH06104624B2 (ja) * | 1986-05-07 | 1994-12-21 | 太郎 小木曽 | 経皮吸収剤 |
DK0473655T3 (da) * | 1989-05-22 | 1997-02-10 | Biochemical Veterinary Res | Divalente metalsalte af indomethacin |
-
1997
- 1997-01-29 FR FR9700925A patent/FR2758819B1/fr not_active Expired - Lifetime
-
1998
- 1998-01-22 MA MA24933A patent/MA24450A1/fr unknown
- 1998-01-28 EP EP98400170A patent/EP0856511B1/de not_active Expired - Lifetime
- 1998-01-28 PT PT98400170T patent/PT856511E/pt unknown
- 1998-01-28 ES ES98400170T patent/ES2217512T3/es not_active Expired - Lifetime
- 1998-01-28 AT AT98400170T patent/ATE260895T1/de not_active IP Right Cessation
- 1998-01-28 DE DE69822009T patent/DE69822009T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
MA24450A1 (fr) | 1998-10-01 |
FR2758819A1 (fr) | 1998-07-31 |
DE69822009D1 (de) | 2004-04-08 |
DE69822009T2 (de) | 2004-10-21 |
ES2217512T3 (es) | 2004-11-01 |
EP0856511B1 (de) | 2004-03-03 |
EP0856511A1 (de) | 1998-08-05 |
PT856511E (pt) | 2004-07-30 |
FR2758819B1 (fr) | 2000-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE415394T1 (de) | Zwischeprodukte zur herstellung von retroviralen protease-hemmern | |
ATE174592T1 (de) | Sulfonamide und derivate zur modulierung der endothelin aktivitat | |
ATE342263T1 (de) | Salze von benzimidazol-derivaten und deren verwendung | |
ATE174872T1 (de) | Carbonierte hydroxyapatit-zusammensetzungen und ihre verwendungen | |
ATE248824T1 (de) | Substituierte phenylderivate, ihre herstellung und verwendung | |
SE9604786D0 (sv) | New compounds | |
FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
FI861506A0 (fi) | Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra). | |
ATE73670T1 (de) | Lysozyme hydrochlorid und dikaliumglycyrrhizinat enthaltende loesung. | |
DE59509910D1 (de) | Verfahren zur Herstellung von Alkylhydrogenchlorsilanen | |
ATE44381T1 (de) | Heterocyclische verbindungen und ihre herstellung und verwendung. | |
ATE141272T1 (de) | Beta-lactam-verbindungen und ihre herstellung | |
ATE138925T1 (de) | Erythromycinderivate, herstellung und verwendung davon | |
TW228520B (de) | ||
ES547129A0 (es) | Un procedimiento para la produccion de derivados de benzoilurea. | |
ATE260895T1 (de) | Indometacin calciumsalz pentahydrat und deren herstellung | |
DE69005984D1 (de) | 2-Hydroxy-3-phenoxypropylaminoverbindungen. | |
ATE290096T1 (de) | Coenzym zur herstellung von l-carnitin | |
FR2753972B1 (fr) | Composition de lactitol et son procede de preparation | |
FI901277A0 (fi) | 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ. | |
NO304314B1 (no) | Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler | |
ATE192141T1 (de) | Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung | |
DK0520372T3 (da) | Inositol-phosphat-analoger som calciumantagonistiske stoffer | |
ATE183502T1 (de) | Octahydro-2-naphthalincarbonsäure-derivate, ihre herstellung und verwendung | |
DE69916134D1 (de) | Herstellung von optisch aktiver cyclohexylphenylglykolsäure und ihrer ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |